Loading insider details...
Beta
Latest Form 4 (Oct 14, 2026): Purchase of 2,470 INBX shares, $207.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 14, 2026 | Inhibrx Biosciences, Inc. (INBX) | Purchase | 2,470 | $207.7K |
| Sep 28, 2026 | Inhibrx Biosciences, Inc. (INBX) | Purchase | 3,324 | $328.6K |
| Sep 8, 2026 | Inhibrx Biosciences, Inc. (INBX) | Purchase | 5,895 | $585.3K |
| Sep 16, 2024 | Inhibrx Biosciences, Inc. (INBX) | Purchase | 26,963 | $405.8K |
| Sep 10, 2024 | Inhibrx Biosciences, Inc. (INBX) | Purchase | 26,000 | $397.5K |
| Sep 3, 2024 | Inhibrx Biosciences, Inc. (INBX) | Purchase | 10,000 | $140.3K |
| Aug 22, 2024 | Inhibrx Biosciences, Inc. (INBX) | Purchase | 27,055 | $350.9K |
| May 30, 2024 | Inhibrx Biosciences, Inc. (INXB) | Grant/Award | 621,548 | n/a |
| May 30, 2024 | Inhibrx, Inc. (INBX) | Disposition to Issuer | 2,486,192 | $74.59M |